Related Experiment Video

Updated: Jun 23, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

Advances in childhood vasculitis

Despina Eleftheriou1, Michael J Dillon, Paul A Brogan

  • 1Department of Paediatric Rheumatology, Institute of Child Health and Great Ormond St Hospital for Children, London, UK. d.eleftheriou@ich.ucl.ac.uk

Current Opinion in Rheumatology
|May 5, 2009
PubMed

Insights

Recent advancements in pediatric vasculitis include new classification criteria and improved treatments like biologics. Ongoing research focuses on genetic factors and long-term cardiovascular health in affected children.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Childhood vasculitis encompasses a group of rare autoimmune diseases affecting blood vessels in children.
  • Understanding the pathogenesis, classification, and treatment of these conditions is crucial for improving patient outcomes.

Purpose of the Study:

  • To review recent developments in the field of pediatric vasculitis.
  • To highlight advancements in classification, etiology, genetics, and therapeutic strategies.

Main Methods:

  • Review of current literature on pediatric vasculitis.
  • Analysis of proposed classification criteria and genetic studies.
  • Evaluation of emerging treatment modalities, including biologic agents.

Main Results:

  • New classification criteria for childhood vasculitis are under validation.
  • Infectious triggers remain relevant for Kawasaki disease and Henoch-Schonlein purpura.
  • Genetic polymorphisms are associated with disease predisposition and complications.
  • Treatment regimens are evolving with immunosuppressants and biologics.
  • Long-term cardiovascular morbidity and endothelial health present ongoing challenges.

Conclusions:

  • Advances in understanding pathogenesis have led to novel therapeutic approaches.
  • International collaboration is essential for standardizing research and treatment in pediatric vasculitis.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...